Talk face to face with Boehringer-Ingelheim »
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with approximately 50,000 employees. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.
Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. Please visit www.boehringer-ingelheim.us/csr to learn more about how we make more health through our Corporate Social Responsibility initiatives.
In 2017, Boehringer Ingelheim achieved net sales of about $20.4 billion (18.1 billion euros). R&D expenditure corresponds to approximately $3.4 billion (three billion euros), or 17.0 percent of its net sales.
Contact:
Tarik Attar
Interstitial Lung Disease
Sales Consultant
San Diego
E-mail - tarik.attar@boehringer-ingelheim.com
Brian McCrary
Interstitial Lung Disease
SoCal-VA-UCsystems-Kaiser
E-mail - brian.mccrary@boehringer-ingelheim.com
